• BRAIN Biotech published its fiscal 2024/25 sustainability report, identifying climate change as its most significant sustainability issue.
• The group targets a 30% reduction in Scope 1 and 2 emissions relative to comparable revenue by 2032.
• Its long-term goal is net-zero Scope 1 and 2 emissions by 2050.
• A double materiality assessment classified 21 of 65 sustainability-related impacts, risks and opportunities as material, underpinning six strategic ESG focus areas.
• Women are targeted to hold 30% of leadership positions by 2032.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BRAIN Biotech AG published the original content used to generate this news brief on November 05, 2026, and is solely responsible for the information contained therein.